Clinical Trials · NCT05796388

A Study of Virtual Reality and Linaclotide for IBS-C

RecruitingN/ALinaclotide (Investigational)
Phase
N/A
Recruitment status
Recruiting
Sponsor
Mayo Clinic
Enrollment
65
Start date
May 2024
Locations
1 site, United States
Primary endpoint
Changes in IBS symptoms
View Linaclotide compound reference